Cargando…
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Small airway dysfunction (SAD) in asthma is characterized by the inflammation and narrowing of airways with less of 2 mm in diameter between generations 8 and 23 of the bronchial tree. It is now widely accepted that small airways are involved in the pathogenesis of asthma and are a major determinant...
Autores principales: | Lombardi, Carlo, Cottini, Marcello, Berti, Alvise, Comberiati, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575249/ https://www.ncbi.nlm.nih.gov/pubmed/36253809 http://dx.doi.org/10.1186/s40733-022-00088-2 |
Ejemplares similares
-
Small airway dysfunction and poor asthma control: a dangerous liaison
por: Cottini, Marcello, et al.
Publicado: (2021) -
Asthma and COVID-19: a dangerous liaison?
por: Lombardi, Carlo, et al.
Publicado: (2021) -
Small Airways: The “Silent Zone” of 2021 GINA Report?
por: Cottini, Marcello, et al.
Publicado: (2022) -
Using the 6-min walk test to assess the clinical response to mepolizumab and conventional therapy in severe eosinophilic asthma
por: Lombardi, Carlo, et al.
Publicado: (2023) -
Small airway dysfunction and bronchial asthma control : the state of the art
por: Cottini, Marcello, et al.
Publicado: (2015)